James Rusche, PhD, Sr. Vice President, Research and Development, Repligen Corporation, discusses the work his company has done to identify development candidate for Friedreich's Ataxia.
Subscribe to:
Post Comments (Atom)
Popular Posts
-
Cleft lip and cleft palate, which can also occur together as cleft lip and palate are variations of a type of clefting congenital deformity ... -
Irritable bowel syndrome (IBS) is a functional bowel disorder characterized by mild to severe abdominal pain, discomfort, bloating and alter...
-
Cell membrane (also called the plasma membrane, plasmalemma, or "phospholipid bilayer") is a selectively permeable lipid bilayer f...
-
DNA extraction is a routine procedure to collect DNA for subsequent molecular or forensic analysis. There are three basic steps in a DNA ext...
-
The olfactory system is the sensory system used for olfaction. Most mammals and reptiles have two distinct parts to their olfactory system: ...
-
Ron Levy, MD, professor of Medicine at Stanford, recounts his experiences moving his discovery from the lab to the clinical setting and disc...
-
Ribosomes (from ribonucleic acid and "greek: soma (meaning body)") are complexes of RNA and protein that are found in all cells. P...
-
A bacteriophage (from 'bacteria' and Greek phagein, 'to eat') is any one of a number of viruses that infect bacteria. The te...
No comments:
Write comments